BECTON DICKINSON & CO
BDX
34 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Jun 27 12:47 AM | Michael FeldEVP, Chief Revenue Officer | Sale | 75 | $152.80 | $11.5K | 21,009(D) | View → |
| Jun 26, 2026 | Jun 26 8:26 PM | MICHAEL FELD | Proposed Sale | 75 | $151.38 | $11.4K | — | View → |
| Jun 24, 2026 | Jun 25 2:16 PM | Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $145.66 | $160.2K | 13,172(D) | View → |
| Jun 24, 2026 | Jun 24 8:38 PM | MICHAEL GARRISON | Proposed Sale | 1,100 | $143.92 | $158.3K | — | View → |
| Jun 10, 2026 | Jun 11 9:21 PM | Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $151.48 | $166.6K | 14,272(D) | View → |
| Jun 10, 2026 | Jun 10 8:29 PM | MICHAEL GARRISON | Proposed Sale | 1,100 | $152.04 | $167.2K | — | View → |
| Jun 1, 2026 | Jun 3 4:44 PM | Thomas E Polen JrDirector, Chairman, CEO and President | Sale | 2,764 | $146.35 | $404.5K | 110,163(D) | View → |
| Jun 1, 2026 | Jun 1 8:21 PM | THOMAS POLEN | Proposed Sale | 2,764 | $147.12 | $406.6K | — | View → |
| May 26, 2026 | May 27 5:41 PM | Michael FeldEVP, Chief Revenue Officer | Sale | 75 | $147.35 | $11.1K | 21,084(D) | View → |
| May 26, 2026 | May 26 8:47 PM | MICHAEL FELD | Proposed Sale | 75 | $147.63 | $11.1K | — | View → |
| Apr 27, 2026 | Apr 28 11:44 AM | Michael FeldEVP, Chief Revenue Officer | Sale | 74 | $151.94 | $11.2K | 21,159(D) | View → |
| Apr 27, 2026 | Apr 27 8:34 PM | MICHAEL FELD | Proposed Sale | 74 | $152.14 | $11.3K | — | View → |
| Mar 26, 2026 | Mar 27 5:49 PM | Michael FeldEVP, Chief Revenue Officer | Sale | 75 | $156.83 | $11.8K | 21,233(D) | View → |
| Mar 26, 2026 | Mar 26 8:24 PM | MICHAEL FELD | Proposed Sale | 75 | $158.27 | $11.9K | — | View → |
| Feb 26, 2026 | Feb 27 10:45 PM | Michael FeldEVP, Chief Revenue Officer | Sale | 75 | $181.84 | $13.6K | 21,308(D) | View → |
| Feb 26, 2026 | Feb 26 9:26 PM | MICHAEL FELD | Proposed Sale | 75 | $180.96 | $13.6K | — | View → |
| Feb 20, 2026 | Feb 20 9:24 PM | DAVID MICHEL SHAN | Proposed Sale | 5,422 | $184.14 | $998.4K | — | View → |
| Feb 20, 2026 | Feb 20 9:20 PM | CHRISTOPHER DELOREFICE | Proposed Sale | 11,305 | $183.91 | $2.1M | — | View → |
| Feb 18, 2026 | Feb 18 10:20 PM | Bertram L ScottDirector | Sale | 953 | $182.61 | $174.0K | 36,763(D) | View → |
| Feb 18, 2026 | Feb 18 9:10 PM | CHRISTOPHER DELOREFICE | Proposed Sale | 9,366 | $182.46 | $1.7M | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3 4:44 PM | Thomas E Polen JrDirector, Chairman, CEO and President | Option Exercise | 20,209 | — | 0(D) | View → |
| May 8, 2026 | May 8 9:26 PM | Robert Luther HuffinesDirector | Grant/Award | 210 | — | 404(D) | View → |
| May 8, 2026 | May 8 9:25 PM | Carrie L ByingtonDirector | Grant/Award | 105 | — | 3,699(D) | View → |
| Feb 4, 2026 | Feb 5 5:24 PM | Robert Luther HuffinesDirector | Grant/Award | 100 | — | 100(D) | View → |
| Feb 4, 2026 | Feb 5 5:21 PM | Carrie L ByingtonDirector | Grant/Award | 30 | — | 1,714(D) | View → |
| Feb 4, 2026 | Feb 5 5:18 PM | Christopher Ian Montague JonesDirector | Grant/Award | 272 | — | 11,649(D) | View → |
| Jan 15, 2026 | Jan 16 8:43 PM | Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | Option Exercise | 3,054 | $167.91 | 0(D) | View → |